Every time I speak with senior leaders about workforce capacity, the conversation inevitably drifts toward the NHS. There is a widespread, unspoken assumption that because we have a national health service, an employer’s primary job is simply to wait for it to fix their people. But let's be entirely clear-eyed about its design limits: the NHS is fundamentally a clinical treatment system, not an employer-facing data platform. It does not exist to answer the commercial questions that HR, Finance and Risk teams must resolve every single month: what is driving absence, where are the hotspots, which risks are rising, and which interventions will materially change cost and capacity? Even when NHS performance ticks upward, its operating model will always prioritise patient care over employer analytics.
What I see repeatedly is organisations failing to recognise that workforce health has shifted from an employee engagement side topic to a critical balance-sheet issue. Consider the scale of the challenge: the HSE reported an estimated 1.9 million workers suffering from work-related ill health in 2024/25, with stress, depression or anxiety acting as the primary driver, and 40.1 million working days lost to work-related ill health and injury. The NHS can help your employees access care, but it cannot tell you how much of that productivity burden is concentrated in a single directorate, contract type, location or job family.
Why the data gap persists
The core problem is structural fragmentation. NHS data is built around service demand, clinical pathways and population health, while employers need operational intelligence tied directly to their own workforce structure, absence patterns, benefits usage and risk exposure. These are fundamentally different questions, asked on different timetables, with entirely different definitions of success. As a result, organisations often receive healthcare information that is too late, too general or too disconnected from their own people data to support any meaningful intervention planning.
This disconnect becomes blindingly obvious when you look at sickness absence and waiting-time pressure. ONS data for 2024 showed 148.9 million working days lost to sickness or injury, even after an improvement on the previous year, with women’s absence rates remaining consistently higher than men’s. Meanwhile, NHS England’s own releases show the elective backlog still sitting in the millions, even as waiting lists have fallen from their peak. This underscores a simple commercial truth that I constantly remind leadership teams of: a health issue sitting in a treatment queue is already an active productivity drain for the business. Quite simply, employers cannot afford to wait for a clinical system to turn into a management dashboard.
What employer health intelligence does differently
Employer health intelligence closes this gap by combining HR, absence, claims, occupational health, benefits, questionnaire and engagement data into a usable, cohesive risk picture. This is not about employee surveillance; it is about looking at your workforce as a portfolio of evolving health risks, each carrying different operational consequences. When done well, it reveals not only who is off work, but precisely why absence is recurring, where capability is deteriorating and which risk controls are actively failing.
This is where the commercial value becomes unmistakable. CIPD’s 2025 Health and wellbeing at work research shows that many organisations still operate reactively rather than proactively, and a substantial share do not yet have a formal wellbeing strategy. In practice, that means employers are still paying for absence after the fact instead of preventing it upstream. Employer health intelligence flips the sequence entirely: you identify the risk, segment the workforce, target the interventions, and then measure whether absence, claims and presenteeism actually move.
The business case for leadership
For HR, the implications are immediate. Without better intelligence, wellbeing becomes a generic benefit offer rather than a risk-managed programme. HR then struggles to defend investment, prioritise interventions or prove whether occupational health, mental health support and case management are reducing time lost. A better data model also helps HR avoid the common error of treating all absence as equal when the underlying causes, durations and cost implications are materially different.
For Finance, the issue is predictability. Absence is not just a payroll variance; it is a capacity and continuity problem that wreaks havoc on overtime, agency spend, service levels and output. The HSE’s estimate of £22.9 billion as the annual cost of workplace injury and new cases of work-related ill health in 2023/24 is a stark reminder that poor workforce health has macroeconomic scale. However, each employer still needs its own microeconomic view. Finance leaders should therefore ask whether current data can identify cost concentration early enough to influence budgets, rather than simply reporting historical losses.
For Risk leaders, the question is governance. Workforce health risk is increasingly linked to operational resilience, regulatory exposure and duty-of-care expectations. If leaders cannot see the early indicators of stress, musculoskeletal strain, long-term condition prevalence or recurring absence, they are managing risk with rear-view mirror information. That is not a tolerable position in a period when the NHS remains under immense strain and access delays can prolong absence or delay return to work.
How to act now
The best C-suite response is not to replace the NHS, but to complement it with employer-grade intelligence.
- First, organisations should establish a single workforce health dataset that brings together absence, occupational health, employee assistance, benefits utilisation and demographic data.
- Second, they should segment that data by job family, location, shift pattern and business unit so that interventions are operationally relevant rather than broad and expensive.
- Third, they should build a joint HR, Finance and Risk review rhythm so health trends are discussed alongside labour costs, productivity and service continuity.
- Fourth, move from passive reporting to active triage. If a cluster of absence is linked to musculoskeletal issues, mental health strain or delayed treatment pathways, the response should be targeted case management, manager support and early intervention—not another generic wellbeing campaign.
- Finally, organisations must measure outcomes in business terms: reduced days lost, improved return-to-work rates, lower repeat absence, and better forecasting accuracy. That is what turns health data into genuine management intelligence.
The next standard
At 78, the NHS still matters profoundly, but its value to employers is limited by design. If you continue to rely on it as your primary source of workforce health insight, you will remain under-informed, slower to act and weaker on cost control. Stop treating health as an uncontrollable externality. The organisations that outperform will be the ones that treat employee health as a managed risk category, build their own evidence base, and use the NHS as part of a wider intelligence model rather than the whole of it.